To provide a forum fr sharing experiences of statistical and methodological issues relating to clinical trials impacted by COVID-19, clinical trials investigating new treatments for COVID-19 and diagnostic/antibody tests for COVID-19.
Who we are
|Name ||Company/Institution |
|James Bell ||BI |
|Lars Endahl ||Novo Nordisk |
|Chrissie Fletcher (Co-Chair)||GSK |
|Christine Hicking ||Merck |
|Achim Guettner ||Novartis |
|Khadija Rantell ||MHRA |
|Andrea Schulze ||Bayer |
|Tri Tat ||CROS NT |
|Marcel Wolbers ||Roche |
|David Wright (Co-Chair)||AstraZeneca |
How can you become involved with the SIG?
would like to become an active member of the COVID-19 SIG and drive forward it’s activities, please send an email to Chrissie